Joseph Jimenez

Verified

Managing Director at Aditum Bio ManagementListed on SEC Form ADVOakland, United States

Claim this profile

Cold

Check Size

Not yet known

Reliability Score

🎯100% of deals in Healthcare

Investment Timeline

Tempero Bio

Board seat (SEC Form D)Source

Since Nov 2025

Company last raised Nov 2025

Via Nova Therapeutics

Board seat (SEC Form D)Source

Since Sep 2021

Company last raised Sep 2021

Portfolio Breakdown

By Sector

Healthcare2 deals · 100%

By Stage

2 tracked deals1 sector · 0 stages

Deal Velocity

Avg Deals / Year

0.4

Avg Deal Size

Unknown

Largest Deal

Tempero Bio

Unknown

YoY Trend

Accelerating

Deals Per Year

2 total deals tracked2021–2025

Investment Activity Map

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

2021

2022

2023

2024

2025

Less

Current Fund Status

Fund Name

Aditum Bio Fund 2, L.P.

Reported Size

$179.6M

Co-Investors

No co-investment data available yet.